questionsmedicales.fr
Lipides
Alcools gras
Hexanols
Cyclohexanols
Cyclohexanols : Questions médicales fréquentes
Termes MeSH sélectionnés :
Obsessive-Compulsive Disorder
Diagnostic
5
Intoxication
Cyclohexanols
Tests de laboratoire
Cyclohexanols
Marqueurs biologiques
Cyclohexanols
Effets à long terme
Cyclohexanols
Symptômes
5
Effets neurologiques
Cyclohexanols
Intoxication chronique
Cyclohexanols
Système immunitaire
Cyclohexanols
Prévention
5
Réglementations
Cyclohexanols
Sensibilisation
Travailleurs
Produits ménagers
Cyclohexanols
Traitements
5
Irritation cutanée
Traitement
Suivi médical
Cyclohexanols
Complications
5
Complications
Cyclohexanols
Reproduction
Cyclohexanols
Réversibilité
Cyclohexanols
Facteurs de risque
5
Facteurs de risque
Travailleurs
Femmes enceintes
Facteurs de risque
Antécédents médicaux
Facteurs de risque
Conditions de travail
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Cyclohexanols : Questions médicales les plus fréquentes",
"headline": "Cyclohexanols : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Cyclohexanols : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-30",
"dateModified": "2025-04-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Cyclohexanols"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hexanols",
"url": "https://questionsmedicales.fr/mesh/D000441",
"about": {
"@type": "MedicalCondition",
"name": "Hexanols",
"code": {
"@type": "MedicalCode",
"code": "D000441",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.289.510"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Succinate de dèsvenlafaxine",
"alternateName": "Desvenlafaxine Succinate",
"url": "https://questionsmedicales.fr/mesh/D000069468",
"about": {
"@type": "MedicalCondition",
"name": "Succinate de dèsvenlafaxine",
"code": {
"@type": "MedicalCode",
"code": "D000069468",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.289.510.500.303"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Eucalyptol",
"alternateName": "Eucalyptol",
"url": "https://questionsmedicales.fr/mesh/D000077591",
"about": {
"@type": "MedicalCondition",
"name": "Eucalyptol",
"code": {
"@type": "MedicalCode",
"code": "D000077591",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.289.510.500.454"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Menthol",
"alternateName": "Menthol",
"url": "https://questionsmedicales.fr/mesh/D008610",
"about": {
"@type": "MedicalCondition",
"name": "Menthol",
"code": {
"@type": "MedicalCode",
"code": "D008610",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.289.510.500.605"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tramadol",
"alternateName": "Tramadol",
"url": "https://questionsmedicales.fr/mesh/D014147",
"about": {
"@type": "MedicalCondition",
"name": "Tramadol",
"code": {
"@type": "MedicalCode",
"code": "D014147",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.289.510.500.802"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chlorhydrate de venlafaxine",
"alternateName": "Venlafaxine Hydrochloride",
"url": "https://questionsmedicales.fr/mesh/D000069470",
"about": {
"@type": "MedicalCondition",
"name": "Chlorhydrate de venlafaxine",
"code": {
"@type": "MedicalCode",
"code": "D000069470",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.289.510.500.901"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Cyclohexanols",
"alternateName": "Cyclohexanols",
"code": {
"@type": "MedicalCode",
"code": "D003511",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Rohan Karande",
"url": "https://questionsmedicales.fr/author/Rohan%20Karande",
"affiliation": {
"@type": "Organization",
"name": "Department of Solar Materials Helmholtz-Centre for Environmental Research, UFZ Permoserstrasse 15, 04318 Leipzig, Germany."
}
},
{
"@type": "Person",
"name": "Ingeborg Heuschkel",
"url": "https://questionsmedicales.fr/author/Ingeborg%20Heuschkel",
"affiliation": {
"@type": "Organization",
"name": "Department of Solar Materials Helmholtz-Centre for Environmental Research, UFZ Permoserstrasse 15, 04318 Leipzig, Germany."
}
},
{
"@type": "Person",
"name": "Anna Hoschek",
"url": "https://questionsmedicales.fr/author/Anna%20Hoschek",
"affiliation": {
"@type": "Organization",
"name": "Department of Solar Materials Helmholtz-Centre for Environmental Research, UFZ Permoserstrasse 15, 04318 Leipzig, Germany."
}
},
{
"@type": "Person",
"name": "Andreas Schmid",
"url": "https://questionsmedicales.fr/author/Andreas%20Schmid",
"affiliation": {
"@type": "Organization",
"name": "Department of Solar Materials Helmholtz-Centre for Environmental Research, UFZ Permoserstrasse 15, 04318 Leipzig, Germany."
}
},
{
"@type": "Person",
"name": "Bruno Bühler",
"url": "https://questionsmedicales.fr/author/Bruno%20B%C3%BChler",
"affiliation": {
"@type": "Organization",
"name": "Department of Solar Materials Helmholtz-Centre for Environmental Research, UFZ Permoserstrasse 15, 04318 Leipzig, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "[Treatment of obsessive-compulsive disorders: recommendations of the revised S3 guidelines on obsessive-compulsive disorders].",
"datePublished": "2022-06-28",
"url": "https://questionsmedicales.fr/article/35763051",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00115-022-01336-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Childhood Obsessive-Compulsive Disorder.",
"datePublished": "2022-12-26",
"url": "https://questionsmedicales.fr/article/36740357",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.psc.2022.10.002"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Neurobiology of obsessive-compulsive disorder].",
"datePublished": "2022-06-20",
"url": "https://questionsmedicales.fr/article/35725830",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00115-022-01331-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Taboo obsessions and their association with suicidality in obsessive-compulsive disorder.",
"datePublished": "2022-07-31",
"url": "https://questionsmedicales.fr/article/35933855",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jpsychires.2022.07.044"
}
},
{
"@type": "ScholarlyArticle",
"name": "A study of doubt in obsessive-compulsive disorder.",
"datePublished": "2023-03-13",
"url": "https://questionsmedicales.fr/article/37247970",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jbtep.2022.101753"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Lipides",
"item": "https://questionsmedicales.fr/mesh/D008055"
},
{
"@type": "ListItem",
"position": 3,
"name": "Alcools gras",
"item": "https://questionsmedicales.fr/mesh/D005233"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hexanols",
"item": "https://questionsmedicales.fr/mesh/D000441"
},
{
"@type": "ListItem",
"position": 5,
"name": "Cyclohexanols",
"item": "https://questionsmedicales.fr/mesh/D003511"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Cyclohexanols - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Cyclohexanols",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Cyclohexanols",
"description": "Comment diagnostiquer une intoxication aux cyclohexanols ?\nQuels tests sont utilisés pour évaluer l'exposition ?\nQuels symptômes indiquent une exposition aux cyclohexanols ?\nY a-t-il des marqueurs biologiques spécifiques ?\nComment évaluer les effets à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D003511?mesh_terms=Obsessive-Compulsive+Disorder#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Cyclohexanols",
"description": "Quels sont les symptômes d'une exposition aiguë ?\nLes cyclohexanols provoquent-ils des irritations ?\nY a-t-il des effets neurologiques ?\nQuels sont les signes d'une intoxication chronique ?\nLes cyclohexanols affectent-ils le système immunitaire ?",
"url": "https://questionsmedicales.fr/mesh/D003511?mesh_terms=Obsessive-Compulsive+Disorder#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Cyclohexanols",
"description": "Comment prévenir l'exposition aux cyclohexanols ?\nY a-t-il des réglementations sur leur utilisation ?\nQuels sont les conseils de sécurité en laboratoire ?\nComment sensibiliser les travailleurs ?\nLes cyclohexanols sont-ils dangereux à domicile ?",
"url": "https://questionsmedicales.fr/mesh/D003511?mesh_terms=Obsessive-Compulsive+Disorder#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Cyclohexanols",
"description": "Quel est le traitement d'une intoxication aiguë ?\nDes antidotes existent-ils pour les cyclohexanols ?\nComment traiter les irritations cutanées ?\nQuel suivi est nécessaire après une exposition ?\nLes traitements varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D003511?mesh_terms=Obsessive-Compulsive+Disorder#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Cyclohexanols",
"description": "Quelles complications peuvent survenir après exposition ?\nLes cyclohexanols peuvent-ils causer des cancers ?\nY a-t-il des effets sur la reproduction ?\nComment gérer les complications à long terme ?\nLes effets sont-ils réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D003511?mesh_terms=Obsessive-Compulsive+Disorder#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Cyclohexanols",
"description": "Qui est le plus à risque d'exposition ?\nL'âge influence-t-il le risque d'exposition ?\nLes femmes enceintes sont-elles plus à risque ?\nLes antécédents médicaux influencent-ils le risque ?\nLes conditions de travail affectent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D003511?mesh_terms=Obsessive-Compulsive+Disorder#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux cyclohexanols ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests sanguins pour détecter les niveaux de cyclohexanols."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'exposition ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang et d'urine peuvent être effectuées pour mesurer les concentrations de cyclohexanols."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une exposition aux cyclohexanols ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des vertiges, et des irritations cutanées."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques spécifiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de marqueurs biologiques spécifiques, mais des niveaux élevés dans le sang peuvent indiquer une exposition."
}
},
{
"@type": "Question",
"name": "Comment évaluer les effets à long terme ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des évaluations cliniques et des suivis réguliers sont nécessaires pour détecter des effets chroniques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une exposition aiguë ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes aigus incluent des nausées, des vomissements, et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les cyclohexanols provoquent-ils des irritations ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent causer des irritations cutanées et des troubles respiratoires en cas d'inhalation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets neurologiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut entraîner des effets neurologiques tels que des troubles de la coordination."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une intoxication chronique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent fatigue, troubles de la mémoire et changements d'humeur."
}
},
{
"@type": "Question",
"name": "Les cyclohexanols affectent-ils le système immunitaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent qu'une exposition prolongée peut altérer la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux cyclohexanols ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle et assurer une ventilation adéquate lors de l'utilisation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des réglementations sur leur utilisation ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réglementations existent pour limiter l'exposition professionnelle aux cyclohexanols."
}
},
{
"@type": "Question",
"name": "Quels sont les conseils de sécurité en laboratoire ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Porter des gants, des lunettes de protection et travailler sous hotte pour minimiser l'exposition."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser les travailleurs ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des formations régulières sur les risques et les mesures de sécurité doivent être mises en place."
}
},
{
"@type": "Question",
"name": "Les cyclohexanols sont-ils dangereux à domicile ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être présents dans certains produits ménagers, il faut donc lire les étiquettes."
}
},
{
"@type": "Question",
"name": "Quel est le traitement d'une intoxication aiguë ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut l'élimination de l'exposition et des soins symptomatiques, comme l'hydratation."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les cyclohexanols ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique pour les cyclohexanols, le traitement est symptomatique."
}
},
{
"@type": "Question",
"name": "Comment traiter les irritations cutanées ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les irritations cutanées peuvent être traitées avec des crèmes apaisantes et des antihistaminiques."
}
},
{
"@type": "Question",
"name": "Quel suivi est nécessaire après une exposition ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical est recommandé pour surveiller les effets à long terme et les complications."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon l'âge ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent varier en fonction de l'âge et de l'état de santé général du patient."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après exposition ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles respiratoires chroniques et des effets neurologiques persistants."
}
},
{
"@type": "Question",
"name": "Les cyclohexanols peuvent-ils causer des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un potentiel cancérigène, mais des recherches supplémentaires sont nécessaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets sur la reproduction ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut affecter la fertilité et le développement fœtal."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications à long terme ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et des interventions thérapeutiques peuvent aider à gérer les complications."
}
},
{
"@type": "Question",
"name": "Les effets sont-ils réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains effets peuvent être réversibles, mais d'autres peuvent persister même après l'arrêt de l'exposition."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'exposition ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs dans l'industrie chimique et ceux manipulant des solvants sont les plus à risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'exposition ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes travailleurs peuvent être moins conscients des risques, augmentant leur vulnérabilité."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition pendant la grossesse peut avoir des effets néfastes sur le fœtus."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes ayant des antécédents respiratoires ou neurologiques sont à risque accru."
}
},
{
"@type": "Question",
"name": "Les conditions de travail affectent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conditions de travail non sécurisées augmentent le risque d'exposition aux cyclohexanols."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 26/04/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Solar Materials Helmholtz-Centre for Environmental Research, UFZ Permoserstrasse 15, 04318 Leipzig, Germany.
Publications dans "Cyclohexanols" :
3 publications dans cette catégorie
Affiliations :
Department of Solar Materials Helmholtz-Centre for Environmental Research, UFZ Permoserstrasse 15, 04318 Leipzig, Germany.
Publications dans "Cyclohexanols" :
3 publications dans cette catégorie
Affiliations :
Department of Solar Materials Helmholtz-Centre for Environmental Research, UFZ Permoserstrasse 15, 04318 Leipzig, Germany.
Publications dans "Cyclohexanols" :
3 publications dans cette catégorie
Affiliations :
Department of Solar Materials Helmholtz-Centre for Environmental Research, UFZ Permoserstrasse 15, 04318 Leipzig, Germany.
Publications dans "Cyclohexanols" :
3 publications dans cette catégorie
Affiliations :
Department of Solar Materials Helmholtz-Centre for Environmental Research, UFZ Permoserstrasse 15, 04318 Leipzig, Germany.
Publications dans "Cyclohexanols" :
3 publications dans cette catégorie
Affiliations :
Department of Solar Materials Helmholtz-Centre for Environmental Research, UFZ Permoserstrasse 15, 04318 Leipzig, Germany.
Publications dans "Cyclohexanols" :
3 publications dans cette catégorie
Affiliations :
Pharmacology, Toxicology and Therapeutics, Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
Publications dans "Cyclohexanols" :
2 publications dans cette catégorie
Affiliations :
Departamento de Química Física y Química Inorgánica - IU CINQUIMA, Facultad de Ciencias, Universidad de Valladolid, E-47011 Valladolid, Spain. lesarri@qf.uva.es.
Publications dans "Cyclohexanols" :
2 publications dans cette catégorie
Publications dans "Cyclohexanols" :
2 publications dans cette catégorie
Publications dans "Cyclohexanols" :
2 publications dans cette catégorie
Affiliations :
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Pharmacology, Toxicology and Therapeutics, Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
Publications dans "Cyclohexanols" :
2 publications dans cette catégorie
Affiliations :
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Publications dans "Cyclohexanols" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology, Physiology and Neuroscience, Rutgers, State University of New Jersey, Newark, NJ, USA.
Publications dans "Cyclohexanols" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology, Physiology and Neuroscience, Rutgers, State University of New Jersey, Newark, NJ, USA.
Publications dans "Cyclohexanols" :
2 publications dans cette catégorie
Affiliations :
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Publications dans "Cyclohexanols" :
2 publications dans cette catégorie
Affiliations :
Pharmacology, Toxicology and Therapeutics, Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
Publications dans "Cyclohexanols" :
1 publication dans cette catégorie
Publications dans "Cyclohexanols" :
1 publication dans cette catégorie
Publications dans "Cyclohexanols" :
1 publication dans cette catégorie
Publications dans "Cyclohexanols" :
1 publication dans cette catégorie
Affiliations :
Stoddart Institute of Molecular Science, Department of Chemistry, Zhejiang University, Hangzhou 310058, P. R. China. mingzhelee@zju.edu.cn.
Zhejiang-Israel Joint Laboratory of Self-Assembling Functional Materials, ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 311215, P. R. China.
Publications dans "Cyclohexanols" :
In 2022, the first revised version of the S3 guidelines on obsessive-compulsive disorder will be published under the auspices of the German Society for Psychiatry, Psychotherapy and Psychosomatics (DG...
Obsessive-compulsive disorder (OCD) frequently affects children and adolescents, with most cases beginning during this time. Symptoms of OCD in youth may present as exaggerated developmental concerns ...
Obsessive-compulsive disorder (OCD) is a frequent mental disorder that leads to an enormous impairment in the quality of life. Cognitive-behavioral explanatory approaches are well established. Scienti...
This article reviews current research findings and the etiopathophysiological considerations derived from them....
An overview of the genetic, epigenetic, structural, functional, and neurochemical alterations in OCD is presented. Additionally, the possible organic causes that can trigger obsessive-compulsive sympt...
With respect to OCD a moderate heritability is assumed. On a molecular level, genetic variants and epigenetic variations in the serotonergic, dopaminergic and glutamatergic systems in particular seem ...
The neurobiology of OCD is partially understood and categorized in an integrative neurobiological model. For the rare secondary immunological causes the concept of "autoimmune OCD" has recently been p...
Individuals with obsessive-compulsive disorder (OCD) more often think about, attempt, and die by suicide than individuals from the general population. Sexual and religious obsessions (i.e., taboo obse...
Obsessive-compulsive disorder (OCD) has been referred to as the "doubting disease," yet there has been little foundational research on its phenomenology and characteristics. Studies of doubt have reli...
A semi-structured interview about doubt was administered to people with OCD (N = 44) and with subclinical OCD (N = 21)....
Doubt was highly prevalent and manifested as a form of obsession, uncertainty about whether a task was done properly, and/or lack of confidence in memory and perceptions. All participants took action ...
We relied on retrospective report, and the subclinical group was relatively small....
In subclinical and clinical OCD, doubt is pervasive, manifests in three domains, is connected to negative core beliefs, and is highly aversive. Continued empirical study of doubt is essential to prope...
Pharmacological treatment is a mainstay of the care of individuals with obsessive-compulsive disorder. Robust evidence supports the use of the selective serotonin reuptake inhibitors and the older tri...
It is important for psychiatric-mental health nurses and advanced practice nurses to be familiar with clinical presentations and recommended treatment for obsessive-compulsive disorder (OCD) in childr...
Cognitive neuroscientific research has the ability to yield important insights into the complex neurobiological processes underlying obsessive-compulsive disorder (OCD). This article provides an updat...
Embitterment is a persistent emotion that is known to everybody in reaction to injustice and being let down, associated with feelings of helplessness and hopelessness. People with psychiatric disorder...
Following a semi-structured diagnostic interview, a number of measures were administered to 31 patients with obsessive-compulsive disorder (OCD) [ICD-10 F42.X: mean age 35.2 (SD = 10.7) years] and 31 ...
Patients with OCD scored more than three times higher (mean = 2.0, SD = 1.1) than the healthy participants in the PTEDq (mean = 0.6, SD = 0.8; p < 0.001), but the cut-off of < 2.5 for a clinically rel...
Our findings suggest that embitterment as measured by PTEDq is important in patients with OCD, who are characterized by metacognitive distortions with an injustice of fate as well as a mortification o...
In this paper, I will provide a phenomenological analysis of somatic obsessions at times present in obsessive-compulsive disorder. I will compare two different types of bodily obsessions, which have a...